Old Web
English
Sign In
Acemap
>
authorDetail
>
Idris Ince
Idris Ince
Medicine
Internal medicine
Ruxolitinib
Myelofibrosis
Toxicity
6
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Real Life Turkish Experience Of Venetoclax Treatment In High Risk Myelodysplastic Syndrome And Acute Myeloid Leukemia
2021
Clinical Lymphoma, Myeloma & Leukemia
Aliihsan Gemici
Fahir Ozkalemkas
Mehmet Hilmi Dogu
Atakan Tekinalp
Inci Alacacioglu
Tekin Guney
Idris Ince
Ayfer Geduk
Gulsum Akgun Cagliyan
Senem Maral
Istemi Serin
Eren Gunduz
Volkan Karakuş
Huseyin Saffet Bekoz
Rafet Eren
İbrahim Ethem Pinar
Ahmet Kürşad Güneş
Fatma Deniz Sargın
Ömür Gökmen Sevindik
Show All
Source
Cite
Save
Citations (1)
Comparison of Mitoxantrone - Melphalan and BEAM Conditioning Regimens in Lymphoma Patients
2021
Hematology/Oncology and Stem Cell Therapy
Ahmet Kürşad Güneş
Istemi Serin
Ilknur Demir
Serpil Sarifakiogullari
Salih Sertac Durusoy
Dervis Murad Akkurt
Idris Ince
Gülkan Özkan
Tahir Alper Cinli
Mustafa Pehlivan
Show All
Source
Cite
Save
Citations (0)
An Unusual Case of Acute Invasive Pansinusitis Due to Laceyella sp. in a Febrile Neutropenic Patient with Myelodysplastic Syndrome
2019
Clinical Microbiology Newsletter
Hande Berk
Nefise Oztoprak
Filiz Kizilateş
Derya Seyman
Betil Özhak Baysan
Idris Ince
Erdal Kurtoğlu
Show All
Source
Cite
Save
Citations (0)
Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data
2018
N. Soyer
Ridvan Ali
M. Turgut
I. Haznedaroglu
F Yilmaz
Ismet Aydogdu
Idris Ince
Volkan Karakuş
Show All
Source
Cite
Save
Citations (0)
1